首页> 外文期刊>Frontiers in Pharmacology >Activation of SK/K Ca Channel Attenuates Spinal Cord Ischemia-Reperfusion Injury via Anti-oxidative Activity and Inhibition of Mitochondrial Dysfunction in Rabbits
【24h】

Activation of SK/K Ca Channel Attenuates Spinal Cord Ischemia-Reperfusion Injury via Anti-oxidative Activity and Inhibition of Mitochondrial Dysfunction in Rabbits

机译:SK / K Ca 通道的激活通过抗氧化活性和抑制线粒体功能障碍来减轻脊髓缺血再灌注损伤。

获取原文
           

摘要

Spinal cord ischemia-reperfusion injury (SCI/R) is a rare but devastating disorder with a poor prognosis. Small conductance calcium-activated K ~(+) (SK/K _(Ca)) channels are a family of voltage-independent potassium channels that are shown to participate in the pathological process of several neurological disorders. The aim of this study was to investigate the role of SK/K _(Ca) channels in experimental SCI/R in rabbits. The expression of SK/K _(Ca)1 protein significantly decreased in both cytoplasm and mitochondria in spinal cord tissues after SCI/R. Treatment with 2 mg/kg NS309, a pharmacological activator for SK/K _(Ca) channel, attenuated SCI/R-induced neuronal loss, spinal cord edema and neurological dysfunction. These effects were still observed when the administration was delayed by 6 h after SCI/R initiation. NS309 decreased the levels of oxidative products and promoted activities of antioxidant enzymes in both serum and spinal cord tissues. The results of ELISA assay showed that NS309 markedly decreased levels of pro-inflammatory cytokines while increased anti-inflammatory cytokines levels after SCI/R. In addition, treatment with NS309 was shown to preserve mitochondrial respiratory complexes activities and enhance mitochondrial biogenesis. The results of western blot analysis showed that NS309 differentially regulated the expression of mitochondrial dynamic proteins. In summary, our results demonstrated that the SK/K _(Ca) channel activator NS309 protects against SCI/R via anti-oxidative activity and inhibition of mitochondrial dysfunction, indicating a therapeutic potential of NS309 for SCI/R.
机译:脊髓缺血再灌注损伤(SCI / R)是一种罕见的但具有毁灭性的疾病,预后较差。小电导钙激活的K〜(+)(SK / K _(Ca))通道是电压依赖性钾通道的一个家族,这些通道被证明参与了几种神经系统疾病的病理过程。这项研究的目的是调查兔实验性SCI / R中SK / K_(Ca)通道的作用。 SCI / R后脊髓组织中SK / K_(Ca)1蛋白的表达在细胞质和线粒体中均显着降低。用2 mg / kg NS309(SK / K_(Ca)通道的药理激活剂)治疗,可减轻SCI / R诱导的神经元丢失,脊髓水肿和神经功能障碍。当开始SCI / R给药6小时后仍能观察到这些效果。 NS309降低了血清和脊髓组织中的氧化产物水平,并增强了抗氧化酶的活性。 ELISA分析的结果表明,SCI / R后NS309显着降低了促炎细胞因子的水平,而增加了抗炎细胞因子的水平。此外,NS309的治疗可保持线粒体呼吸复合物的活性并增强线粒体的生物发生。蛋白质印迹分析的结果表明,NS309差异性调节线粒体动态蛋白的表达。总之,我们的结果表明,SK / K_(Ca)通道激活剂NS309通过抗氧化活性和线粒体功能障碍的抑制作用来防御SCI / R,表明NS309对SCI / R具有治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号